Effects of Phosphatidylserine and DHA on Cognitive Performance in Children With ADHD
NCT07521449, Not applicable, Completed, Çağlar Charles Daniel Jaicks
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Phosphatidylserine and DHA on Cognitive Performance in Children With ADHD | ClinicalTrials.gov |
| NCT number | NCT07521449 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 45 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Çağlar Charles Daniel Jaicks | ClinicalTrials.gov |
| Conditions | Attention Deficit Hyperactivity Disorder (ADHD), ADHD | ClinicalTrials.gov |
| Interventions | Placebo, Phosphatidylserine-Omega3, Phosphatidylserine-Omega3, DHA Omega-3 | ClinicalTrials.gov |
| First posted | 2026-04-13 | ClinicalTrials.gov |
| Last updated | 2026-04-13 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Attention and Executive Function Scores (MOXO and Stroop Tests) | Baseline and 8 weeks | Change from baseline to 8 weeks in cognitive performance assessed using the MOXO continuous performance test (attention, impulsivity, timing, and hyperactivity domains) and the Stroop test (reaction time, error rates, and correction counts). | ClinicalTrials.gov |
| Secondary | Change in MOXO Attention Score | Baseline and 8 weeks | Change from baseline to 8 weeks in attention performance measured by MOXO d-CPT. | ClinicalTrials.gov |
| Secondary | Change in MOXO Impulsivity Score | Baseline and 8 weeks | Change from baseline to 8 weeks in impulsivity measured by MOXO d-CPT. | ClinicalTrials.gov |
| Secondary | Change in MOXO Hyperactivity Score | Baseline and 8 weeks | Change from baseline to 8 weeks in hyperactivity measured by MOXO d-CPT. | ClinicalTrials.gov |
| Secondary | Change in Stroop Reaction Time | Baseline and 8 weeks | Change from baseline to 8 weeks in reaction time measured by the Stroop test. | ClinicalTrials.gov |
| Secondary | Change in Stroop Error Scores | Baseline and 8 weeks | Change from baseline to 8 weeks in error rates measured by the Stroop test. | ClinicalTrials.gov |
| Secondary | Change in Stroop Correction Counts | Baseline and 8 weeks | Change from baseline to 8 weeks in correction counts measured by the Stroop test. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Continuous Performance Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)